Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigens-Reference-Cited by-同舟云学术

Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigens

Published:2022-07-13 Issue:2 Volume:72 Page:287-300
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Cho Helen,Binder Joe,Weeratna Risini,Dermyer Michael,Dai Stanley,Boccia Antionio,Li Wei,Li Shangjin,Jooss Karin,Merson James,Hollingsworth Robert E.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-022-03245-x.pdf

Reference46 articles.

1. Hollingsworth RE, Jansen K (2019) Turning the corner on therapeutic cancer vaccines. Nat Partn J Vaccines 4:7. https://doi.org/10.1038/s41541-019-0103-y

2. Wei SC, Duffy CR, Allison JP (2018) Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov 8(9):1069–1086. https://doi.org/10.1158/2159-8290.CD-18-0367

3. Page DB, Postow MA, Callahan MK et al (2014) Immune modulation in cancer with antibodies. Annu Rev Med 65:185–202. https://doi.org/10.1146/annurev-med-092012-112807

4. Ali OA, Lewin SA, Dranoff G et al (2016) Vaccines combined with immune checkpoint antibodies promote cytotoxic T cell activity and tumoreradication. Cancer Immunol Res 4:95–100. https://doi.org/10.1158/2326-6066.CIR-14-0126

5. Collins JM, Redman JM, Gulley JL (2018) Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy. Expert Rev Vaccines 17(8):697–705. https://doi.org/10.1080/14760584.2018.1506332

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment;Journal of Functional Biomaterials;2024-08-16

2. CD8+ T cell-based cancer immunotherapy;Journal of Translational Medicine;2024-04-29

3. Identification of Immune Subtypes and Candidate mRNA Vaccine Antigens in Small Cell Lung Cancer;The Oncologist;2023-07-03

4. Vaccines as treatments for prostate cancer;Nature Reviews Urology;2023-03-06

5. First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC);Journal for ImmunoTherapy of Cancer;2023-03